Cagrilintide
5mg · 2ml
SKU: cagrilintide-5mg
Long-acting amylin analog for weight management and satiety.
Available Options
Product Specifications
Strength
5mg
Volume / Qty
2ml
Form
Lyophilized Powder
Dosing Guide
Recommended Dose
1-2 mg starting
Route
Subcutaneous
Frequency
Once weekly
Clinician Access Required
Sign in to view clinician pricing & place orders
Cagrilintide is available exclusively to verified clinicians under IRB-approved research protocol PPRN-001-2025.
IRB-Approved Research Protocol
PPRN-001-2025 ·IRCM-2025-467
Approved December 3, 2025 · Principal Investigator: Dr. M. Scott Mortensen, MD, MPAS, MLT
Save up to 80% with the 5,000 Foundation Bundle
Cagrilintide is included in this clinic-tier package. Bundle includes weight loss (tirz & reta) + longevity/repair (mots-c, ghk-cu, bpc-157, epithalon) with 1 free Tirz 15mg as a bonus.
Most popular
Also frequently ordered
What other clinicians put in the same cart.
For Clinicians
Clinical Reference
Pharmacology, safety, monitoring, and dosing reference for Cagrilintide. Always individualize based on patient context.
Mechanism of Action
Receptor / Target
Long-acting amylin analog; binds amylin and calcitonin receptors
Half-Life
~7 days (weekly dosing)
Onset of Action
Satiety within days; weight loss 4–12 weeks
Metabolism
Proteolytic cleavage
Cautions & Contraindications
Contraindicated In
- Hypersensitivity to amylin analogs
- Pregnancy and lactation
Use Caution With
- Severe gastroparesis
- Combined with GLP-1 agonists, monitor for additive GI side effects
- Hypoglycemia risk in insulin-treated diabetics
Suggested Labs to Monitor
HbA1c
Baseline / 12 weeksFasting glucose
Baseline / 12 weeksCMP
Baseline / 12 weeksLab interpretation guidance comes from peer-reviewed literature. Always individualize based on patient context.
Plumb DISCOVER
What Cagrilintide targets
Patient goals, biomarkers, and wearable signals this peptide addresses. Powers the future Plumb AI protocol engine.
Patient Goals
Biomarkers Tracked
Wearable Signals
Clinical Synergy
Frequently stacked with Cagrilintide
Peptides commonly combined with Cagrilintide for synergistic clinical outcomes.
Related Products
SEMA 15mg
Semaglutide is a synthetic GLP-1 receptor agonist that mimics the naturally occurring gut hormone glucagon-like peptide-1 to regulate appetite and metabolism. It strengthens satiety signals, slows gastric emptying, improves insulin secretion, and modulates gut-brain communication to support weight loss and glycemic control.
View Details
AOD-9604 2mg
Fragment of growth hormone for fat metabolism without affecting blood sugar or growth.
View Details
TIRZ 15mg
Tirzepatide is a synthetic dual GIP/GLP-1 receptor agonist that simultaneously activates both glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 pathways. This dual action reduces hunger, slows digestion, stabilizes blood sugar, and promotes long-term metabolic improvements including weight loss and improved body composition.
View Details
RETA 20mg
Retatrutide is a synthetic triple agonist peptide engineered to activate glucagon, GLP-1, and GIP receptors simultaneously. It reduces appetite, slows gastric emptying, improves blood glucose regulation, and enhances energy expenditure through multiple complementary metabolic pathways.
View Details